top of page
Green & blue light beam

Design Isn’t Fairy Dust: Oscar Daws on Keeping Designers at the Table From Concept to Launch

Oct 29
4 min read

Too many medtech teams still treat industrial design as a finishing touch. Engineering builds the device, then a designer comes in near the end to make it look good. Oscar Daws has spent his career pushing against that habit.


Oscar trained as a product designer in the UK and got his start at consultancies in the Cambridge–London–Oxford “Golden Triangle.” About nine years ago he co-founded Tone Product Design in London. The firm works across medical and consumer products, and more and more in the space between them, where medtech and health companies are moving into direct-to-consumer wellness. In this episode, he and Duane talk about where design adds the most value, why packaging is underused, and the mistakes early-stage companies keep making.


Design Belongs in Every Phase

Oscar was direct: “seeing design as the kind of the fairy dust at the end” is one of the most common mistakes he warns clients about. He sees the designer’s job as shaping the interface between a complex technology and the person using it. That includes the housing, the instructions for use, the packaging, and the digital interface, which together make up the patient or user experience. That job starts at the very beginning, when the team is working out what the product should be. It continues through R&D, where designers and engineers work best side by side. Oscar says it matters most during detailed engineering and design transfer, because that’s when bill-of-materials pressure and technical risk start to chip away at the original vision. “There’s really good reasons that those decisions were made to begin with,” he noted. Usually users inform them.


You’re Designing for More Than One User

Duane pointed out that a medical product has many users. The surgeon holds it, but other people store it, buy it, and ship it. Oscar agreed and singled out procurement teams, who may never touch the device but compare its spec sheet against competitors. Each of these stakeholders needs to be understood at the start of the project. “There’s no point in having a transformative technology if it can’t be used by people and people don’t want to use it,” Oscar said.


Packaging and Aesthetics Do Real Work

Oscar called packaging “often underutilized” in medtech. Once the basics are covered, such as protecting the product and maintaining sterility, the packaging becomes the user’s first physical contact with the device. Tone has run projects where the device itself stayed the same and only the packaging and its messaging were redesigned, and usability improved measurably as a result. That’s a real lever for reducing risk. The same goes for aesthetics. Tone translates a client’s brand identity into a three-dimensional “visual design language” covering color, materials, finish, and even how parts feel when they click together. Form also tells users how to use a device: the shape of a button suggests how to press it. “There has to be a reason for everything that’s there,” Oscar said.


Watching Users Is Humbling

Oscar’s favorite part of the job is formative testing, where he hands a prototype to a user without instructions and watches. “You think you’ve thought of everything, and I can guarantee that you haven’t.” He urges clients to put designers in those sessions in person, because a written report misses the brief confusion on someone’s face. Duane added the commercial side. Clearance is the start of learning, not the end. A usability study, the first 30 patients, and the first 1,000 patients will each turn up something new. That’s why he pushes for a limited market release before a broad launch.


Why This Matters

Problems found late cost far more to fix than problems found early. When usability issues come up after design freeze, teams end up patching them with longer instructions instead of fixing the product. For startups turning a promising core technology into something people will buy, bringing design in early and keeping it through launch shapes adoption, risk, and the value story buyers hear. Oscar’s advice for founders comes down to three points: bring design in early, focus on a specific target user before expanding, and defend the design vision all the way to launch.


What to Watch

The line between medical and consumer products keeps blurring. As medtech companies move into direct-to-consumer health and wellness, patients will expect the same polished experience they get from consumer tech, starting with the box it arrives in. Teams that treat design as a strategic function rather than cosmetic polish will be better placed to meet that expectation, especially when Gen 1 is meant to teach and Gen 2 is meant to scale. Oscar and Tone Product Design are working right at that intersection.



Helpful Links


Thank you to our sponsors: Ward Law, Wheelhouse DMG, and JumpStart Inc.


Podcast promo for Project Medtech: Oscar Daws portrait, Episode 284, The Art of Medtech Design, hosted by Duane Mancini.

 
 
 

Comments


bottom of page